Endocrine Disruptors

Key Topics

  • ED in the context of the EU´s Green Deal
  • The US EPA’s Endocrine Disruptor Screening Program (EDSP)
  • OECD Testing Guidelines
  • New Approach Methodologies (NAMs)
  • Impact on CLP


Presenting Institutions and Companies

  • Julien Fabre, European Commission, DG ENV
  • Francesca Pellizzato, European Chemicals Agency (ECHA)
  • Luísa Camacho, Food and Drug Administration (FDA), USA
  • Anne Gourmelon, OECD
  • Prof Dr ZhiChao Dang, National Institute of Public Health and the Environment (RIVM), The Netherlands
  • Jürgen Arning, Federal Environment Agency (UBA), Germany
  • Dr Scott Lynn, Environmental Protection Agency (EPA), USA
  • Dr Volker J. Soballa, Evonik Industries AG, Germany
  • Dr Dan Pickford, Syngenta Crop Protection AG, UK
  • Annegaaike Leopold, ibacon GmbH, Germany
  • Dr James Wheeler, Corteva Agriscience, The Netherlands
  • Prof Dr Lennart Weltje, BASF SE, Germany
  • Helen Tinwell, Bayer SAS, France
  • Dr Bieke Scharlaken,  knoell Germany GmbH
  • Zanda Romata, Steptoe & Johnson LLP, Belgium
  • Prof Taisen Iguchi, National Institute for Basic Biology, Japan